Companies Race To Develop The Next Novel Blockbuster Diabetes Drug

[Northerner]

The American Diabetes Association listed the total cost of diabetes in 2012 as $245 billion, an increase of 41% compared to 2007 when $174 billion was spent. The study also estimated that 22.3 million people were living with type 1 (T1D) or type 2 diabetes (T2D) in 2012, up from 17.5 million in 2007. According to GBI Research, a leading business intelligence provider, the T2D drug market -- which constitutes a significant chunk of the total diabetes drug market -- is expected to grow from $26 billion in 2011 to $50 billion in 2021, in developed markets including the U.S., Japan, and Europe.

http://seekingalpha.com/article/173...e-next-novel-blockbuster-diabetes-drug-part-2